Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCRMatthias Ritgen, Peter Dreger, Thorsten Raff et al.|Blood|2004Cited by 170
Application of Circulating Cell-Free Tumor DNA Profiles for Therapeutic Monitoring and Outcome Prediction in Genetically Heterogeneous Metastatic MelanomaRenáta Váraljai, Alexander Roesch, Kilian Wistuba‐Hamprecht et al.|JCO Precision Oncology|2019Cited by 54
ctDNA as a noninvasive monitoring tool in metastatic melanoma.Renáta Váraljai, Alexander Roesch, Kilian Wistuba‐Hamprecht et al.|Journal of Clinical Oncology|2019Cited by 0